| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.001 |